[Clinical and fundamental studies on ceftriaxone (CTRX) against urinary tract infections].

Author: NishioS, YoshiharaH

Paper Details 
Original Abstract of the Article :
Clinical efficacy of ceftriaxone (CTRX) against complicated urinary tract infections in 20 patients was examined, and the serum CTRX level was also measured in the patients with chronic renal failure (CRF). CTRX was administered at a dose of 1.0 g once a day for 5 to 10 days. The overall clinical ef...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/3177133

データ提供:米国国立医学図書館(NLM)

Ceftriaxone: A Powerful Weapon Against Urinary Tract Infections

This article delves into the effectiveness of ceftriaxone (CTRX) in treating complicated urinary tract infections (UTIs), exploring its efficacy and pharmacokinetics. It's like venturing into the desert of UTIs, searching for a potent weapon to combat this common infection.

Ceftriaxone's Effectiveness: A Promising Remedy

The study found that CTRX was clinically effective in treating complicated UTIs, with an overall efficacy rate of 85%. It successfully eradicated 62.8% of isolated strains after administration. These findings demonstrate the potential of CTRX as a valuable treatment option for UTIs.

Navigating the Desert of Renal Failure

The study also assessed CTRX's pharmacokinetics in patients with chronic renal failure (CRF), finding that CTRX levels remained high and plateaued after injection. This suggests that CTRX may not be effectively removed by hemodialysis, a crucial factor to consider when treating patients with CRF.

Dr.Camel's Conclusion

This study underscores the importance of considering both efficacy and pharmacokinetics when choosing an antibiotic for treating UTIs, particularly in patients with renal impairment. It's like navigating a desert landscape with diverse terrain, requiring a customized approach based on the specific challenges presented. Ceftriaxone offers a promising remedy for UTIs, but its use in patients with CRF requires careful monitoring and consideration.
Date :
  1. Date Completed 1988-11-15
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

3177133

DOI: Digital Object Identifier

3177133

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.